Your search found 1 Results
Ippf Medical Bulletin. 1986 Apr; 20(2):1.This statement sets forth the views of the International Planned Parenthood Federation's (IPPF) International Medical Advisory Panel (IMAP) on the safety of IUD use. There has been concern about the recent withdrawal from the US market by Ortho Pharmaceuticals and GD Searle & Co. of 3 widely used IUDs: Lippes Loop, Copper 7, and Copper T200. It is noted that these actions were taken for commercial reasons related to profitability and/or liability insurance concerns, and not for medical or scientific reasons. The 3 IUDs that were withdrawn from the USmarket continue to be approved for contraceptive use by the US Food and Drug Administration. After extensive review of available data, IMAP at its London meeting in February 1986, reaffirmed its earlier position on the IUD, supporting it as a safe and effective method of contraception. Although concern has been expressed about potential increases in the risks of pelvic inflammatory disease and tubal infertility as a result of IUD use, recent research suggests that women who use copper-bearing devices, particularly married women in primarily monogamous relationships, are a relatively low risk. On the other hand, women with multiple partners, especially nulliparous women, who are already at risk of sexually transmitted diseases, are not good candidates for IUD use. IPPF will continue to provide IUDs upon request to its member associations.